Cambium Medical Technologies jobs and careers
Atlanta, GA, United States
About Cambium Medical Technologies
Cambium Medical Technologies, founded by four blood industry luminaries out of Emory University, Atlanta, Georgia (USA)--is focused on the development and commercialization of regenerative therapies derived from novel processed human platelets. Cambium is developing Elate Ocular a standardized, commercialized platelet derived biologic eye drop fordry eye syndrome (keratoconjunctivis sicca) as its first FDA approved therapy. Elate Ocular is an investigational drug and is not yet approved for sale in or outside the United States.
Founded in 2013 by Edmund Waller, Jacques Galipeau and John Roback.
- Founded
- 2013
- Employees
- 11 to 50
- Total funding
- $5.1M
- Headquarters
- Atlanta
Leadership
The top of Cambium Medical Technologies's org chart, with how many people report into each leader.
Terence A. Walts
President, CEO & Co-Founder
6 reports
Dennis E. Hannigan
VP, Quality Assurance & Regulatory Affairs
1 report
Clayton W. Coley
Corporate Counsel
1 report
Michael Broughton
CFO
Edmund K. Waller
Co-Founder, Director, Medical & Chief Scientific Officer
Board
David Hiller
Advisor
Cheryl L. Rowe-Rendleman
Advisor
Steven Wilson
Medical Advisor
Zuguo Liu
Medical Advisor
Stephen C. Pflugfelder
Medical Advisor
Victor Perez
Medical Advisor
Jobs at Cambium Medical Technologies
No open positions right now. Explore more companies on TheJobsMap.